![](/img/cover-not-exists.png)
Increased Dose Density Is Feasible: A Pilot Study of Adjuvant Epirubicin and Cyclophosphamide followed by Paclitaxel, at 10- or 11-Day Intervals with Filgrastim Support in Women with Breast Cancer
Fornier, M. N., Seidman, A. D., Lake, D., D'Andrea, G., Bromberg, J., Robson, M., Van Poznak, C., Panageas, K. S., Atienza, M., Norton, L., Hudis, C.Volume:
13
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-06-1731
Date:
January, 2007
File:
PDF, 199 KB
english, 2007